fleroxacin has been researched along with carumonam in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Bertasso, A; Georgopapadakou, NH | 1 |
Appelbaum, PC; Spangler, SK; Tamarree, T | 1 |
Kafetzis, DA; Legakis, NJ | 1 |
4 other study(ies) available for fleroxacin and carumonam
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Effects of quinolones on nucleoid segregation in Escherichia coli.
Topics: Anti-Infective Agents; Aztreonam; Cell Nucleus; DNA, Bacterial; Dose-Response Relationship, Drug; Escherichia coli; Fleroxacin; Photomicrography | 1991 |
Susceptibility of 310 nonfermentative gram-negative bacteria to aztreonam, carumonam, ciprofloxacin, ofloxacin and fleroxacin.
Topics: Anti-Bacterial Agents; Aztreonam; Ciprofloxacin; Fleroxacin; Gram-Negative Bacteria; Microbial Sensitivity Tests; Ofloxacin; Oxazines | 1988 |
Comparative activities of three new antibacterial agents with aztreonam against gram-negative bacilli.
Topics: Anti-Bacterial Agents; Aztreonam; Ceftizoxime; Ciprofloxacin; Drug Therapy, Combination; Enterobacteriaceae; Fleroxacin; Gram-Negative Bacteria; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1987 |